CCM Biosciences Launches from Stealth to Advance Portfolio of Proprietary, First-in-Class Therapies and Companion Diagnostic Tests Across Multiple Therapeutic Areas

/PRNewswire/ -- Diversified biotechnology company CCM Biosciences launched from stealth today with more than ten drug programs, many of which originated from...

Related Keywords

India ,France ,United States ,American ,Sudipto Mukherjee ,Manisha Ghosh ,Carnegie Mellon ,Raj Chakrabarti ,Raj Chakrabarti Harvard ,Cleveland Clinic Taussig Cancer Institute ,Chakrabarti Advanced Technology ,Leadership Team ,Princeton University ,Group For The Chemistry ,Ohio State University ,Professor Of Finance At Mcgill University ,National Bureau Of Economic Research ,Group International ,Nucleic Acids Research ,American Chemical Society ,Nature Publishing Group ,Office Of Technology Licensing ,First In Class Drug ,New Drug ,Cleveland Clinic ,Ohio State ,Taussig Cancer Institute ,Deep Expertise ,Scientific Innovation ,Chemical Engineering ,Princeton Phd ,Purdue Universities ,Mcgill University ,Financial Studies ,National Bureau ,Economic Research ,Quantitative Research ,Ccm Biosciences ,